Synlett 2017; 28(15): 2008-2013
DOI: 10.1055/s-0036-1588865
letter
© Georg Thieme Verlag Stuttgart · New York

A Highly Efficient Approach for the Synthesis of Novel Trifluoroacetylated Enaminones using DBU as a Base

P. Kumari
Organic Synthesis Research Laboratory, Department of Chemistry, A.R.S.D. College, University of Delhi, New Delhi 110021, India   Email: sunitabhagat28@gmail.com
,
N. Sharma
Organic Synthesis Research Laboratory, Department of Chemistry, A.R.S.D. College, University of Delhi, New Delhi 110021, India   Email: sunitabhagat28@gmail.com
,
A. Kumar
Organic Synthesis Research Laboratory, Department of Chemistry, A.R.S.D. College, University of Delhi, New Delhi 110021, India   Email: sunitabhagat28@gmail.com
,
S. C. Mohapatra
Organic Synthesis Research Laboratory, Department of Chemistry, A.R.S.D. College, University of Delhi, New Delhi 110021, India   Email: sunitabhagat28@gmail.com
,
S. Bhagat*
Organic Synthesis Research Laboratory, Department of Chemistry, A.R.S.D. College, University of Delhi, New Delhi 110021, India   Email: sunitabhagat28@gmail.com
› Author Affiliations
Further Information

Publication History

Received: 12 April 2017

Accepted after revision: 12 May 2017

Publication Date:
21 June 2017 (online)


Abstract

An efficient methodology has been developed for the synthesis of a variety of novel trifluoroacetylated enaminones by using trifluoroacetic anhydride in DCE as solvent and DBU as a base via electrophilic trifluoroacetylation. X-ray crystallographic studies confirmed the trifluoroacetylation and E stereoisomeric form of the novel compounds. The synthetic strategy has the advantage of using an inexpensive and non-toxic base for producing excellent yields. Synthons bearing variety of functional groups may be further extended for the formation of heterocyclic compounds.

Supporting Information

 
  • References and Notes

    • 1a Gouverneur V. Muller K. Fluorine in Pharmaceutical and Medicinal Chemistry: From Biophysical Aspects to Clinical Applications. Imperial College Press; London: 2012
    • 1b Begue J.-PD. Biorganic and Medicinal Chemistry of Fluorine . Wiley-VCH; Hoboken: 2008
    • 1c Ojima I. Fluorine in Medicinal Chemistry and Chemical Biology . Wiley; Blackwell, Chichester: 2009
    • 2a Ladner Y. D’Orly F. Perre C. Silva B.-D. Guyon C. Tatoulian M. Plasma Process. Polym. 2014; 11: 518
    • 2b Kimura T. Kasuya MC. Hatanaka K. Matsuoka K. Molecules 2016; 21: 358
    • 2c Narita T. Polymer J. 2011; 43: 497
    • 3a Theodoridis G. Adv. fluorine Sci. 2006; 2: 121
    • 3b Ritter SK. Chem. Eng. News 2012; 90: 10
    • 3c Shimizu M. Hiyama T. Angew. Chem. Int. Ed. 2005; 44: 214
    • 4a Franz J.-E. Kaufman R.-J. PCT Int. Appl WO 4180394, 1979
    • 4b Franz J.-E. Kaufman R.-J. PCT Int. Appl WO 4195983, 1980
  • 5 Zhou S. Gu Y. Liu M. Wu C. Zhou S. Zhao Y. Jia Z. Wang B. Xiong L. Yang N. Li Z. J. Agric. Food Chem. 2014; 62: 11054
  • 6 Ohno I. Tomizawa M. Aoshima A. Kumazawa S. Kagabu S. J. Agric. Food Chem. 2010; 58: 4999
  • 8 Roper WL. Toxicological Profile for Pyridine. Toxic Substances and Disease Registry; US Public Health Service: 1992: 52
    • 9a Nikseresht A. Bakavoli M. Bayraq SS. Synth. Commun. 2014; 44: 2662
    • 9b Kumari S. Singh H. Khurana JM. Tetrahedron Lett. 2016; 57: 3081
    • 9c Rajeswari M. Saluja P. Khurana JM. RSC Adv. 2016; 6: 1307
    • 10a Dieter RK. Tetrahedron 1986; 42: 3029
    • 10b Junjappa H. Ila H. Asokan CV. Tetrahedron 1990; 46: 5423
    • 10c Kolb M. Bi X. Liu Q. Chem. Soc. Rev. 2013; 42: 1251
    • 10d Pan L. Liu Q. Synlett 2011; 1073
    • 10e Liu Q. Nielsen MB. Krause N. Marek I. Schaumann E. Wirth T. Science of Synthesis Knowledge Updates 2014/2. Georg Thieme; Stuttgart, Germany: 2014. section 24.2.11.3, 245
    • 10f Wang L. He W. Yu Z. Chem. Soc. Rev. 2013; 42: 599
  • 11 Zhang L. Dong J. Xu J. Liu Q. Chem. Rev. 2016; 116: 287
  • 12 Hojo M. Masuda R. Okada E. Yamamoto H. Morimoto K. Okada K. Synthesis 1990; 195
  • 13 Barabanov MA. Sevenard DV. Sosnovskikh VY. Russ. Chem. Bull., Int. Ed. 2012; 61: 1646
  • 14 Sharma N. Chundawat TS. Mohapatra SC. Bhagat S. Synthesis 2016; 48: 4495
  • 15 Sharma N. Chundawat TS. Mohapatra SC. Bhagat S. RSC Adv. 2013; 3: 16336
  • 16 Sharma N. Kumari N. Chundawat TS. Bhagat S. RSC Adv. 2017; 7: 10150
  • 17 Yang CW. Bai YX. Zhang NT. Zeng CC. Hua LM. Tian HY. Tetrahedron 2012; 68: 10201
  • 18 General Procedure for the Synthesis of Trifluoroacetylated Enaminones 3as: To a solution of enaminones 2as (1 equiv) in DCE (5 mL) was added DBU (2 equiv) under a N2 atmosphere. TFAA (2.5 equiv) was added dropwise over 10 min, keeping the temperature at 0 °C. When addition was complete, the mixture was allowed to warm slowly to r.t. and stirred for 2 h, monitoring by TLC. After completion of the reaction, the mixture was quenched with aq NaHCO3, then washed with dilute HCl and finally H2O. The mixture was extracted with CH2Cl2 and the organic layer was dried over anhyd Na2SO4. After filtering and concentrating by rotary evaporation, a solid product was obtained that was crystallized from Et2O–pentane (5%) to give the pure compounds 3as. (E)-1-(4-Chlorophenyl)-2-[(cyclohexylamino)(methylthio)methylene]-4,4,4-trifluorobutane-1,3-dione (3l): The compound was obtained as a white solid; mp 108–110 °C; yield: 0.36 g (94%). IR (KBr): 3448, 2933, 1726, 1654, 1574, 1460 cm–1. 1H NMR (400 MHz, CDCl3): δ = 12.07 (br s, 1 H, NH), 7.75 (t, J = 8.4 Hz, 2 H), 7.35 (d, J = 8.4 Hz, 2 H), 3.95 (s, 1 H, NHCH), 2.19 (s, 3 H, SMe), 1.87–1.90 (m, 3 H), 1.72–1.74 (m, 2 H), 1.55–1.57 (m, 1 H), 1.24–1.46 (m, 4 H). 13C NMR (100 MHz, CDCl3): δ = 191.17, 174.01 (COCF3), 167.94, 139.44, 137.82, 130.57, 128.83, 128.64, 128.44, 118.75, 115.88 (COCF3), 107.74 (=CCOCF3), 55.21, 33.36, 24.95, 24.16, 19.43 (SMe). 19F NMR (376 MHz, CDCl3): δ = –70.68 (s, 3 F, COCF3). HRMS (ESI): m/z [M + H]+ calcd for C18H19ClF3NO2S: 406.0855; found: 406.0853. (E)-4,4,4-Trifluoro-2-1-(4-chlorophenyl)-2[(methylthio)(propylamino)methylene]-1-[3-(trifluoromethyl)phenyl]butane-1,3-dione (3q): The compound was obtained as a white solid; mp 60–62 °C; yield: 0.37 g (95%). IR (KBr): 3418, 2903, 1723, 1621, 1562, 1464 cm–1. 1H NMR (400 MHz, CDCl3): δ = 11.95 (br s, 1 H, NH), 8.06 (s, 1 H), 7.99 (d, J = 7.6 Hz, 1 H), 7.74 (d, J = 7.6 Hz, 1 H), 7.54 (d J = 7.6 Hz, 1 H), 3.58 (q, J = 6.1 Hz, 2 H), 2.15 (s, 3 H, SMe), 1.65–1.74 (m, 2 H), 1.00 (t, 3 H). 13C NMR (100 MHz, CDCl3): δ = 190.76, 174.42 (COCF3), 169.21, 140.03, 132.26, 129.21, 128.08, 125.77, 115.78 (COCF3), 107.67 (=CCOCF3), 48.06, 23.14, 18.48 (SMe), 11.29 (Me). 19F NMR (376 MHz, CDCl3): δ = –63.73 (s, 3 F, ArCF3), –71.87 (s, 3 F, COCF3). HRMS (ESI): m/z [M + H]+ calcd for C16H15F6NO2S: 400.0806; found: 400.0801.